Cystoscopic Ablation Via RF Energy Clinical Trial

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Overactive Bladder
Interventions
DEVICE

Amphora OAB Device

Cystoscopic procedure to treat OAB

Trial Locations (4)

Unknown

University of Antwerp, Antwerp

University Hospital Ghent, Ghent

University of Calgary, Calgary

University of Sherbrooke, Sherbrooke

Sponsors
All Listed Sponsors
lead

Amphora Medical, Inc.

INDUSTRY

NCT02398578 - Cystoscopic Ablation Via RF Energy Clinical Trial | Biotech Hunter | Biotech Hunter